| Product Code: ETC10939489 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, the Philippines saw a diverse range of vaccine import shipments from top countries including Switzerland, India, South Korea, Germany, and the USA. With a low Herfindahl-Hirschman Index (HHI) indicating low market concentration, the market remains open to various suppliers. Despite a negative compound annual growth rate (CAGR) of -17.36% from 2020 to 2024, the market experienced a significant decline in growth rate from 2023 to 2024 at -47.02%. This suggests potential shifts in market dynamics and emphasizes the importance of monitoring trends in vaccine imports for the Philippines.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Vaccine Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Vaccine Market - Industry Life Cycle |
3.4 Philippines Vaccine Market - Porter's Five Forces |
3.5 Philippines Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Philippines Vaccine Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.7 Philippines Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.8 Philippines Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Philippines Vaccine Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Philippines Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing government initiatives and funding for vaccination programs |
4.2.2 Growing awareness about the importance of vaccination in preventing diseases |
4.2.3 Rise in infectious diseases and outbreaks, driving the demand for vaccines |
4.3 Market Restraints |
4.3.1 Lack of accessibility and affordability of vaccines in remote areas |
4.3.2 Vaccine hesitancy and misinformation leading to lower vaccination rates |
4.3.3 Regulatory challenges and delays in vaccine approvals |
5 Philippines Vaccine Market Trends |
6 Philippines Vaccine Market, By Types |
6.1 Philippines Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Vaccine Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Philippines Vaccine Market Revenues & Volume, By Preventive Vaccines, 2021 - 2031F |
6.1.4 Philippines Vaccine Market Revenues & Volume, By Therapeutic Vaccines, 2021 - 2031F |
6.1.5 Philippines Vaccine Market Revenues & Volume, By DNA Vaccines, 2021 - 2031F |
6.2 Philippines Vaccine Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 Philippines Vaccine Market Revenues & Volume, By Influenza, 2021 - 2031F |
6.2.3 Philippines Vaccine Market Revenues & Volume, By COVID19, 2021 - 2031F |
6.2.4 Philippines Vaccine Market Revenues & Volume, By Hepatitis B, 2021 - 2031F |
6.3 Philippines Vaccine Market, By Age Group |
6.3.1 Overview and Analysis |
6.3.2 Philippines Vaccine Market Revenues & Volume, By Pediatrics, 2021 - 2031F |
6.3.3 Philippines Vaccine Market Revenues & Volume, By Adults, 2021 - 2031F |
6.3.4 Philippines Vaccine Market Revenues & Volume, By Geriatrics, 2021 - 2031F |
6.4 Philippines Vaccine Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Philippines Vaccine Market Revenues & Volume, By Intramuscular, 2021 - 2031F |
6.4.3 Philippines Vaccine Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.4.4 Philippines Vaccine Market Revenues & Volume, By Oral, 2021 - 2031F |
6.5 Philippines Vaccine Market, By Technology |
6.5.1 Overview and Analysis |
6.5.2 Philippines Vaccine Market Revenues & Volume, By mRNAbased, 2021 - 2031F |
6.5.3 Philippines Vaccine Market Revenues & Volume, By Viral Vector, 2021 - 2031F |
6.5.4 Philippines Vaccine Market Revenues & Volume, By Protein Subunit, 2021 - 2031F |
7 Philippines Vaccine Market Import-Export Trade Statistics |
7.1 Philippines Vaccine Market Export to Major Countries |
7.2 Philippines Vaccine Market Imports from Major Countries |
8 Philippines Vaccine Market Key Performance Indicators |
8.1 Immunization coverage rates among different age groups |
8.2 Number of successful vaccination campaigns conducted |
8.3 Rate of vaccine adoption and acceptance in the population |
8.4 Investments in research and development for new vaccines |
8.5 Number of vaccine-preventable disease cases reported |
9 Philippines Vaccine Market - Opportunity Assessment |
9.1 Philippines Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Philippines Vaccine Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.3 Philippines Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.4 Philippines Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Philippines Vaccine Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 Philippines Vaccine Market - Competitive Landscape |
10.1 Philippines Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Philippines Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here